Naloxone in treating central adverse effects during opioid titration for cancer pain

J Pain Symptom Manage. 2003 Aug;26(2):691-3. doi: 10.1016/s0885-3924(03)00250-1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / poisoning*
  • Analgesics, Opioid / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug-Related Side Effects and Adverse Reactions / drug therapy*
  • Humans
  • Lymphoma, Non-Hodgkin / complications*
  • Male
  • Morphine / administration & dosage
  • Morphine / poisoning*
  • Morphine / therapeutic use*
  • Naloxone / therapeutic use*
  • Narcotic Antagonists / therapeutic use*
  • Pain / drug therapy*
  • Pain / etiology*

Substances

  • Analgesics, Opioid
  • Narcotic Antagonists
  • Naloxone
  • Morphine